KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cme (CME) Return on Sales (2016 - 2026)

Cme has reported Return on Sales over the past 18 years, most recently at 0.61% for Q1 2026.

  • Quarterly Return on Sales rose 3.0% to 0.61% in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 0.63% through Mar 2026, up 5.0% year-over-year, with the annual reading at 0.62% for FY2025, 5.0% up from the prior year.
  • Return on Sales was 0.61% for Q1 2026 at Cme, down from 0.72% in the prior quarter.
  • Over five years, Return on Sales peaked at 0.72% in Q4 2025 and troughed at 0.53% in Q1 2022.
  • The 5-year median for Return on Sales is 0.57% (2024), against an average of 0.58%.
  • Biggest five-year swings in Return on Sales: dropped -28bps in 2022 and later grew 14bps in 2025.
  • Tracing CME's Return on Sales over 5 years: stood at 0.53% in 2022, then increased by 7bps to 0.57% in 2023, then increased by 1bps to 0.57% in 2024, then increased by 25bps to 0.72% in 2025, then dropped by -14bps to 0.61% in 2026.
  • According to Business Quant data, Return on Sales over the past three periods came in at 0.61%, 0.72%, and 0.59% for Q1 2026, Q4 2025, and Q3 2025 respectively.